These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34607935)

  • 1. Topical Nasal Decongestant Oxymetazoline: Safety Considerations for Perioperative Pediatric Use.
    Cartabuke R; Tobias JD; Jatana KR;
    Pediatrics; 2021 Nov; 148(5):. PubMed ID: 34607935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxymetazoline and hypertensive crisis in a child: can we prevent it?
    Latham GJ; Jardine DS
    Paediatr Anaesth; 2013 Oct; 23(10):952-6. PubMed ID: 23679077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended use of topical nasal decongestants.
    Yoo JK; Seikaly H; Calhoun KH
    Laryngoscope; 1997 Jan; 107(1):40-3. PubMed ID: 9001263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.
    Watanabe H; Foo TH; Djazaeri B; Duncombe P; Mackay IS; Durham SR
    Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasal decongestants in monotherapy for the common cold.
    Deckx L; De Sutter AI; Guo L; Mir NA; van Driel ML
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD009612. PubMed ID: 27748955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The observation of the ciliotoxicity of nasal mucosa with nasal decongestant].
    Teng Y; Zhang X; Xu G; Cai Q; Xu J
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Sep; 19(18):824-6. PubMed ID: 16375111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thunderclap headache and reversible segmental cerebral vasoconstriction associated with use of oxymetazoline nasal spray.
    Loewen AH; Hudon ME; Hill MD
    CMAJ; 2004 Sep; 171(6):593-4. PubMed ID: 15367461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paranasal sinusitis after long-term use of topical nasal decongestants.
    Min YG; Kim HS; Suh SH; Jeon SY; Son YI; Yoon S
    Acta Otolaryngol; 1996 May; 116(3):465-71. PubMed ID: 8790749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Not Just a Drop in the Bucket-Inversion of Oxymetazoline Nasal Decongestant Container Increases Potential for Severe Pediatric Poisoning.
    Nordt SP; Vivero LE; Cantrell FL
    J Pediatr; 2016 Jan; 168():240-241. PubMed ID: 26522979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute coronary syndrome after nasal spray of oxymetazoline.
    Montastruc F; Montastruc G; Taudou MJ; Olivier-Abbal P; Montastruc JL; Bondon-Guitton E
    Chest; 2014 Dec; 146(6):e214-e215. PubMed ID: 25451367
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative evaluation of nasal blood flow and airflow in the decongestant response to oxymetazoline.
    Vaidyanathan S; Williamson P; Lipworth B
    Ann Allergy Asthma Immunol; 2012 Feb; 108(2):77-80. PubMed ID: 22289724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of nasal response following different treatment regimes of oxymetazoline with reference to rebound congestion.
    Morris S; Eccles R; Martez SJ; Riker DK; Witek TJ
    Am J Rhinol; 1997; 11(2):109-15. PubMed ID: 9129752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of oxymetazoline in nasal endoscopic sinus surgery].
    Zhen H; Gao Q; Cui Y; Hua X; Li H; Feng J
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 May; 17(5):281-2. PubMed ID: 12916356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of 0.05% oxymetazoline (Vicks Sinex Micromist®) nasal spray in the treatment of objective nasal congestion demonstrated to 12 h post-administration by magnetic resonance imaging.
    Pritchard S; Glover M; Guthrie G; Brum J; Ramsey D; Kappler G; Thomas P; Stuart S; Hull D; Gowland P
    Pulm Pharmacol Ther; 2014 Feb; 27(1):121-6. PubMed ID: 23988443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-ST-elevation myocardial infarction with the use of oxymetazoline nasal spray.
    Rajpal S; Morris LA; Akkus NI
    Rev Port Cardiol; 2014 Jan; 33(1):51.e1-4. PubMed ID: 24405558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. By the way, doctor. The air in my apartment gets exceedingly dry during the winter. I started using a nasal decongestant containing oxymetazoline hydrochloride. Now I'm hooked. Even when it's not winter, I can't breathe at night without it. How can I break this addiction?
    Mushlin S
    Harv Health Lett; 2006 Oct; 31(12):8. PubMed ID: 17152641
    [No Abstract]   [Full Text] [Related]  

  • 17. Topical nasal decongestant oxymetazoline (0.05%) provides relief of nasal symptoms for 12 hours.
    Druce HM; Ramsey DL; Karnati S; Carr AN
    Rhinology; 2018 Dec; 56(4):343-350. PubMed ID: 29785414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of topical administration of nasal decongestants and vasoconstrictors in paediatric nasal surgery - A systematic review.
    Macmillan AJ; Phoon KM; Edafe O
    Int J Pediatr Otorhinolaryngol; 2022 Feb; 153():111010. PubMed ID: 34942425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic and pharmacokinetic analysis of oxymetazoline use during nasal surgery in children.
    Cartabuke RS; Anderson BJ; Elmaraghy C; Rice J; Tumin D; Tobias JD
    Laryngoscope; 2019 Dec; 129(12):2775-2781. PubMed ID: 30786035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anterior ischemic optic neuropathy following the use of a nasal decongestant.
    Fivgas GD; Newman NJ
    Am J Ophthalmol; 1999 Jan; 127(1):104-6. PubMed ID: 9933016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.